Article

The Japan TimesThe Japan Times on 2022-02-04 03:16

COVID’s endemic shift means a slowdown for virus-product makers

Demand for at-home tests will probably slow first while sales of more reliable PCRs will show more resilience, according to medical supply executives.

Related news